Gilbertsville, PA 4/9/13—Rockland Immunochemicals, a provider of research reagents, has acquired the Epi-Plus antibody product line from 21st Century Biochemicals for an undisclosed amount. According to Rockland, the Epi-Plus antibodies are the most well-validated antibodies for epigenetics research. “The fact that the Epi-Plus brand is co-owned by Novus Biologicals also allows us to expand the Rockland brand globally,” stated Rockland President and CEO Jim Fendrick.